Recital 2, Regulation (EU) 2021/578

In forcesince 29 Jan 2021

Since the establishment of the European Surveillance of Veterinary Antimicrobial Consumption (ESVAC) project [https://www.ema.europa.eu/en/veterinary-regulatory/overview/antimicrobial-resistance/european-surveillance-veterinary-antimicrobial-consumption-esvac] in 2010 by the European Medicines Agency (‘the Agency’) at the request of the Commission, data on the volume of sales of veterinary antimicrobial agents for use in animals have been collected and reported following a harmonised approach at European level. All Member States, as well as Norway, Iceland and Switzerland participated in that project. Participating countries have reported on a voluntary basis the national sales figures of veterinary medicinal products classified as antibiotics and antiprotozoals with antibiotic effect. The data collected and the analyses carried out constituted a solid reference for the adoption of national action plans against antimicrobial resistance or other measures to promote prudent and responsible use of antimicrobials.